Rebalanced hemostasis in patients with idiopathic thrombocytopenic purpura

References

• Chong BH. Diagnosis, treatment and pathophysiology of autoimmune thrombocytopenias. Crit Rev Oncol Hematol 1995;20:271–296
   PubMed Web of Science ®Google Scholar
• Wang ZY, Shen ZX. Megakaryocytes and platelets in immune thrombocytopenic purpura. Baillieres Clin Haematol 1997;10:89–107
   PubMed Web of Science ®Google Scholar
• Gorton H, Lyons G. Is it time to invest in a thromboelastograph? Int J Obstet Anesth 1999;8:171–178
   PubMed Web of Science ®Google Scholar
• Kenet G, Lubetsky A, Shenkman B, Tamarin I, Dardik R, Rechavi G, Barzilai A, Martinowitz U, Savion N, Varon D. Cone and platelet analyser (CPA): A new test for the prediction of bleeding among thrombocytopenic patients. Br J Haematol 1998;101:255–259
   PubMed Web of Science ®Google Scholar
• Mallett SV, Platt M. Role of thrombelastography in bleeding diatheses and regional anaesthesia. Lancet 1991;338:765–766
   PubMed Web of Science ®Google Scholar
• Oshita K, Az-ma T, Osawa Y, Yuge O. Quantitative measurement of thromboelastography as a function of platelet count. Anesth Analg 1999;89:296–299
   PubMed Web of Science ®Google Scholar
• Gunduz E, Akay OM, Bal C, Gulbas Z. Can thrombelastography be a new tool to assess bleeding risk in patients with idiopathic thrombocytopenic purpura? Platelets 2011;22:516–520
   PubMed Web of Science ®Google Scholar
• Rossi M, Lewis M, Hutchinson N. Coronary artery bypass grafting in idiopathic thrombocytopenia: Use of thromboelastometry without platelet transfusion. Tex Heart Inst J 2010;37:361–364
   Google Scholar
• James KM, Melikian CN, Chowdary P, Mallett SV. Thromboelastography-guided recombinant factor VIIa administration in a patient with refractory autoimmune idiopathic thrombocytopenia. Anesth Analg 2008;107:402–405
   Google Scholar
• Campos CJ, Pivalizza EG, Abouleish EI. Thromboelastography in a parturient with immune thrombocytopenic purpura. Anesth Analg 1998;86:675
   Google Scholar
• Tripodi A, Mannucci PM. Abnormalities of hemostasis in chronic liver disease: Reappraisal of their clinical significance and need for clinical and laboratory research. J Hepatol 2007;46:727–733
   PubMed Web of Science ®Google Scholar
• Caldwell SH, Hoffman M, Lisman T, Macik BG, Northup PG, Reddy KR, Tripodi A, Sanyal AJ. Coagulation disorders and hemostasis in liver disease: Pathophysiology and critical assessment of current management. Hepatology 2006;44:1039–1046
   PubMed Web of Science ®Google Scholar
• Lisman T, Caldwell SH, Leebeek FW, Porte RJ. Is chronic liver disease associated with a bleeding diathesis? J Thromb Haemost 2006;4:2059–2060
   Google Scholar
• Warnaar N, Lisman T, Porte RJ. The two tales of coagulation in liver transplantation. Curr Opin Organ Transplant 2008;13:298–303
   Google Scholar
• Mannucci PM. Abnormal hemostasis tests and bleeding in chronic liver disease: Are they related? No. J Thromb Haemost 2006;4:721–723
   Web of Science ®Google Scholar
• van der Werf J, Porte RJ, Lisman T. Hemostasis in patients with liver disease. Acta Gastroenterol Belg 2009;72:433–440
   Google Scholar
• Massicotte L, Lenis S, Thibeault L, Sassine MP, Seal RF, Roy A. Effect of low central venous pressure and phlebotomy on blood product transfusion requirements during liver transplantations. Liver Transpl 2006;12:117–123
   PubMed Web of Science ®Google Scholar
• de Boer MT, Molenaar IQ, Hendriks HG, Slooff MJ, Porte RJ. Minimizing blood loss in liver transplantation: Progress through research and evolution of techniques. Dig Surg 2005;22:265–275
   Google Scholar
• Ferro D, Quintarelli C, Lattuada A, Leo R, Alessandroni M, Mannucci PM, Violi F. High plasma levels of von Willebrand factor as a marker of endothelial perturbation in cirrhosis: Relationship to endotoxemia. Hepatology 1996;23:1377–1383
   Google Scholar
• Hollestelle MJ, Geertzen HG, Straatsburg IH, van Gulik TM, van Mourik JA. Factor VIII expression in liver disease. Thromb Haemost 2004;91:267–275
   PubMed Web of Science ®Google Scholar
• Lisman T, Bongers TN, Adelmeijer J, Janssen HL, de Maat MP, de Groot PG, Leebeek FW. Elevated levels of von Willebrand Factor in cirrhosis support platelet adhesion despite reduced functional capacity. Hepatology 2006;44:53–61
   PubMed Web of Science ®Google Scholar
• Kang YG, Martin DJ, Marquez J, Lewis JH, Bontempo FA, Shaw BW Jr., Starzl TE, Winter PM. Intraoperative changes in blood coagulation and thrombelastographic monitoring in liver transplantation. Anesth Analg 1985;64:888–896
   PubMed Web of Science ®Google Scholar
• Salooja N, Perry DJ. Thrombelastography. Blood Coagul Fibrinolysis 2001;12:327–337
   PubMed Web of Science ®Google Scholar
• Chen A, Teruya J. Global hemostasis testing thromboelastography: Old technology, new applications. Clin Lab Med 2009;29:391–407
   PubMed Web of Science ®Google Scholar
• Navalgund AA, Kang Y, Sarner JB, Jahr JS, Gieraerts R. Massive pulmonary thromboembolism during liver transplantation. Anesth Analg 1988;67:400–402
   Google Scholar
• Moore JC, Hayward CP, Warkentin TE, Kelton JG. Decreased von Willebrand factor protease activity associated with thrombocytopenic disorders. Blood 2001;98:1842–1846
   PubMed Web of Science ®Google Scholar
• Kojouri K, Vesely SK, Terrell DR, George JN. Splenectomy for adult patients with idiopathic thrombocytopenic purpura: A systematic review to assess long-term platelet count responses, prediction of response, and surgical complications. Blood 2004;104:2623–2634
   PubMed Web of Science ®Google Scholar
• Gibson M, Sehon JK, White S, Zibari GB, Johnson LW. Splenectomy for idiopathic thrombocytopenic purpura: A five-year retrospective review. Am Surg 2000;66:952–954; discussion 955
   Google Scholar
• Favaloro EJ, Soltani S, McDonald J, Grezchnik E, Easton L, Favaloro JW. Reassessment of ABO blood group, sex, and age on laboratory parameters used to diagnose von Willebrand disorder: Potential influence on the diagnosis vs the potential association with risk of thrombosis. Am J Clin Pathol 2005;124:910–917
   Google Scholar